This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atrialfibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians.
tim.hodson Thu, 04/24/2025 - 10:37 April 23, 2025 The Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an AtrialFibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients. million adults. 2024; 84(16): 1501-8.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrialfibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Circulation.
BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. The most productive journals were Europace and the Journal of Interventional Cardiac Electrophysiology. The institution with the largest output was The Icahn School of Medicine at Mount Sinai.
ABSTRACT Background Sotalol is used for the maintenance of sinus rhythm among patients with atrialfibrillation. Methods In the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry, we analyzed outcomes among patients undergoing elective IV sotalol load for atrialarrhythmias (AT/AF).
Introduction Catheter ablation is an effective and safe strategy for treating atrialfibrillation patients. Method Patient baseline characteristics and electrophysiological parameters were examined to identify the predictors of atrialfibrillation recurrence following catheter ablation.
Timely evaluation and management of athletes with atrialfibrillation (AF), the most common arrhythmia in Masters athletes, is critical to ensuring safe and efficient return to play.
ABSTRACT Introduction In atrialfibrillation (AF) ablation procedures, the CARTO VIZIGO Bidirectional Guiding Sheath has previously shown promising results in reducing fluoroscopy times without compromising clinical effectiveness or safety compared with non-steerable sheaths. Results Of 199 patients included (mean age, 69.7
Evidence suggests a reduced incidence of ventricular and atrialarrhythmias in patients with dapagliflozin or empagliflozin treatment. It is unclear to what extent the reduced arrhythmia burden is due to direct effects of the SGLT2 inhibitors or is solely a marker of improved cardiac function.
Patients who present with persistent atrialfibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrialfibrillation (AFib).
Age is an independent risk factor for the development of atrialfibrillation (AF). While AF arises in old age, the combined effects of widespread structural, electrophysiological and autonomic remodeling make it difficult to discern the exact mechanisms of arrhythmia generation.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:The strongest genetic risk factors for atrialfibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor genePITX2.
Atrialfibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrialfibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.
Abstract Background and Aims Atrialfibrillation is the most prevalent cardiac arrhythmia, and catheter ablation (CA) has emerged as a viable treatment option for selected patients. However, its safety profile in liver cirrhosis (LC) populations remains underexplored.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Three months after the index procedure, patients underwent a repeat electrophysiology study to identify pulmonary vein reconnections. Forty patients underwent a repeat electrophysiology study. or acute reconnection (4% versus 14%;P=0.3)
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study.
She also has a hx of paroxysmal atrialfibrillation and is on oral anticoagulant treatment. the most commonly overlooked arrhythmia ( See My Comment at the bottom of the page in the May 1, 2023 — and the November 12, 2019 post , among others ). The last echocardiography 12 months ago showed HFmrEF.
Atrialfibrillation (AF) is the most common heart arrhythmia and considered to be a progressive chronic disease associated with an increased morbidity and mortality. Recent data suggests a link between inflammation, oxidative stress and AF, although the underlying mechanisms are not fully understood.
Abstract Introduction Atrialfibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Atrial fibrillation is the most common cardiac arrhythmia in the world and increases the risk for stroke and morbidity.
Studies have shown that mutations in the RYR2 gene, which encodes the RyR2 protein, are linked to several cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome (LQTS), calcium release deficiency syndrome (CRDS), and atrialfibrillation (AF).
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
At present we do not have any reliable intra-procedural electrophysiologic predictors of long-term success of AF ablation other than pulmonary vein isolation. Patients were followed (median 20 months) for recurrent atrialarrhythmias as the primary end point of the study. Results PV capture was identified in 20.3%
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:It is difficult to identify patients with atrialfibrillation (AF) most likely to respond to ablation.
BACKGROUND:The relationship between heart failure (HF) and atrialfibrillation (AF) is clear, with up to half of patients with HF progressing to AF. The pathophysiological basis of AF in the context of HF is presumed to result from atrial remodeling. We found that FOG2 repressed atrial gene expression promoted byTBX5.
Median nerve stimulation (MNS) is a non-invasive low-level electrical stimulation therapy which, in early studies, favorably affects atrialelectrophysiology and reduces inflammation. The autonomic nervous system is important in the initiation and maintenance of AF.
Catheter ablation of atrialfibrillation in infiltrative cardiomyopathies ABSTRACT Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. AF is the most common arrhythmia identified in patients with amyloidosis due to cellular infiltration and atrial dilation.
Since the patient was stable and tolerating the arrhythmia it was decided to treat with IV Amiodarone for medical conversion. Whenever it is this fast, you need to be very careful to ascertain whether it is irregular ( as in atrialfibrillation with rapid ventricular respsonse ) or regular ( as in VT ). It is not VT; it is AF.
Transhepatic (TH) access has been used in patients with interrupted inferior vena cava (IVC) for various electrophysiology procedures. However, there is no published data in the use of pulsed field ablation (PFA), rapidly becoming the ablation modality of choice for atrialarrhythmias, in patients with interrupted IVCs.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Pulmonary vein isolation (PVI) alone is less effective in patients with persistent atrialfibrillation (AF) compared with those with paroxysmal AF. to 3.4%]; hazard ratio, 0.66 [95% CI, 0.460.94]).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content